Ischemic and Hemorrhagic Complications after Intra-Arterial Fibrinolysis in Vertebrobasilar Occlusion

References

1. ↵
   Labauge R, Pages M, Blard JM. Survie prolongee apres occlusion du tronc basilaire. Rev Neurol 1981;145:789–94
2. ↵
   Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216–22

   Abstract/FREE Full Text
3. ↵
   Levy EI, Firlik AD, Wisniewski S, et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999;45:539–48

   CrossRefPubMedWeb of Science
4. ↵
   Schulte-Altedorneburg G, Hamann GF, Mull M, et al. Outcome of acute vertebrobasilar occlusions treated with local intra-arterial fibrinolysis in 180 cases. AJNR Am J Neuroradiol 2006;27:2042–47.

   Abstract/FREE Full Text
5. ↵
   Eckert B, Kucinski T, Pfeiffer G, et al. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002;14:42–50

   CrossRefPubMedWeb of Science
6. ↵
   Cross DT, Derdeyn CP, Moran CJ. Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activator. AJNR Am J Neuroradiol 2001;22:521–25

   Abstract/FREE Full Text
7. ↵
   Anonymous. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932–36

   PubMed
8. ↵
   Zeumer H, Freitag HJ, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (rtPA). Neuroradiology 1993;35:159–62

   CrossRefPubMedWeb of Science
9. ↵
   Gulba DC, Bode C, Runge MS, et al. Thrombolytic agents—an overview. Ann Hematol 1996;73(Suppl. II):S9–27
10. ↵
    del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11.

    Abstract/FREE Full Text
11. ↵
    Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study, a randomized controlled trial. JAMA 1999;282:2003–11

    CrossRefPubMedWeb of Science
12. Arnold M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002;33:1828–33

    Abstract/FREE Full Text
13. ↵
    Eckert B, Kucinski T, Neumaier-Probst E, et al. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome. Cerebrovasc Dis 2003;15:258–63

    CrossRefPubMedWeb of Science
14. ↵
    Brandt T, von Kummer R, Muller Kuppers M, et al. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 1996;27:875–81

    Abstract/FREE Full Text
15. ↵
    Arnold M, Nedeltchev K, Schroth G, et al. Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75:857–62

    Abstract/FREE Full Text
16. ↵
    Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. N Engl J Med 1995;333:1581–87

    CrossRefPubMedWeb of Science
17. ↵
    Mayer TE, Hamann GF, Brueckmann H. Treatment of basilar artery embolism with mechanical extraction device: necessity of flow reversal. Stroke 2002;33:2232–35

    Abstract/FREE Full Text
18. ↵
    Mayer TE, Hamann GF, Schulte-Altedorneburg G, et al. Treatment of vertebrobasilar occlusion by using a coronary waterjet thrombectomy device: a pilot study. AJNR Am J Neuroradiol 2005;26:1389–94

    Abstract/FREE Full Text
19. ↵
    Nesbit GM, Luh G, Tien R, et al. New and future endovascular treatment strategies for acute ischemic stroke. J Vasc Interv Radiol 2004;15:S103–10

    CrossRefPubMed
20. ↵
    Eckert B, Koch C, Thomalla G, et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion. Combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST)—results of a multicenter study. Stroke 2005;36:1160–65

    Abstract/FREE Full Text
21. Bergui M, Stura G, Daniele D, et al. Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first line treatment. Stroke 2006;37:145–50.

    Abstract/FREE Full Text
22. Wikholm G. Transarterial embolectomy in acute stroke. AJNR Am J Neuroradiol 2003;24:892–94

    Abstract/FREE Full Text
23. ↵
    Mangiafico S, Cellerini M, Nencini P, et al. Intravenous glycoprotein IIb/IIIa inhibitor (Tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol 2005;26:2595–601

    Abstract/FREE Full Text